Prise en charge ambulatoire du syndrome de sevrage de l'alcool [Ambulatory management of alcohol withdrawal syndrome].

Détails

ID Serval
serval:BIB_D402E846123D
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Prise en charge ambulatoire du syndrome de sevrage de l'alcool [Ambulatory management of alcohol withdrawal syndrome].
Périodique
Praxis
Auteur⸱e⸱s
Yersin B.
ISSN
1661-8157 (Print)
ISSN-L
1661-8157
Statut éditorial
Publié
Date de publication
1999
Volume
88
Numéro
42
Pages
1705-1709
Langue
français
Notes
Publication types: English Abstract ; Journal Article
Publication Status: ppublish
Résumé
The alcohol withdrawal syndrome occurs in the hours or days after the cessation of alcohol drinking in an alcohol dependent patient. The alcohol withdrawal syndrome is produced by the emergence of the biological mechanism of neurological tolerance to ethanol. The clinical manifestations of the alcohol withdrawal syndrome are due to the hyperexcitability of the central nervous system: agitation, excitability, tremor, convulsions, status epilepticus, delirium, sympathetic hyperactivity. Usually benign, the alcohol withdrawal syndrome is frequently manageable on an ambulatory basis, as long as no clinical counter-indication is present such as a serious previous alcohol withdrawal syndrome, previous withdrawal convulsions, a significant medical or psychiatric comorbidity, a high level of alcohol consumption, a pregnancy, or the lack of an effective familial or social support. The ambulatory management of the alcohol withdrawal syndrome requires frequently the use of a sedative drug. Benzodiazepines used orally for a duration of 3 to 5 days are actually considered a first choice. Inability to work and drive is frequently present for several days.
Mots-clé
Alcohol Withdrawal Delirium/rehabilitation, Alcoholism/rehabilitation, Ambulatory Care, Anti-Anxiety Agents/administration & dosage, Anti-Anxiety Agents/adverse effects, Benzodiazepines, Dose-Response Relationship, Drug, Drug Administration Schedule, Female, Humans, Male, Patient Admission, Pregnancy
Pubmed
Création de la notice
24/01/2008 16:31
Dernière modification de la notice
20/08/2019 15:54
Données d'usage